Ascendis Pharma A/S Overview
Valuation check: ASND's ROE is 103.71%, above the Healthcare sector average of 29.33%.
Get informed when a big investor buys or sells
+ Follow103.71%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, ASND shows a ROE of 103.71%. That is above the Healthcare sector average of 29.33%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 29.33%. Ascendis Pharma A/S is at 103.71%, which is higher that average. That is roughly 253.6% above the sector mean. Use the comparison chart on this page to see how ASND stacks up against individual peers as well.
Check the historical chart to see whether ASND's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ascendis Pharma A/S with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 103.71%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 29.33%, while ASND is at 103.71%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
